低血糖、胰岛素类似物；处方成本还是生活质量？ - Suppr

Suppr

超能文献

Hypoglycaemia, analogue insulins; prescribing cost or quality of life?

作者信息

Hitman G A

出版信息

Diabet Med. 2012 Mar;29(3):289. doi: 10.1111/j.1464-5491.2012.03583.x.

DOI:10.1111/j.1464-5491.2012.03583.x

PMID:22364579

Abstract

摘要

相似文献

Hypoglycaemia, analogue insulins; prescribing cost or quality of life?

Diabet Med. 2012 Mar;29(3):289. doi: 10.1111/j.1464-5491.2012.03583.x.

[Are the short-acting insulin analogs superfluous?].

MMW Fortschr Med. 2006 Mar 16;148(11):17.

Insulin lispro: a pharmacoeconomic review of its use in diabetes mellitus.

Pharmacoeconomics. 2002;20(14):989-1025. doi: 10.2165/00019053-200220140-00004.

Long-acting insulin analogs versus human insulins.

Diabetes Technol Ther. 2008 Oct;10(5):331-2. doi: 10.1089/dia.2008.0071.

Hypoglycaemia: costs, insulins and prevention.

Diabet Med. 2016 Apr;33(4):419-20. doi: 10.1111/dme.13100.

Evaluation of exenatide vs. insulin glargine in type 2 diabetes: cost-effectiveness analysis in the German setting.

Diabetes Obes Metab. 2009 Nov;11(11):1068-79. doi: 10.1111/j.1463-1326.2009.01099.x. Epub 2009 Sep 3.

[Economics under scrutiny - experts discuss long acting insulin analogs].

Pflege Z. 2011 Jan;64(1):58.

Cost-effectiveness of insulin analogues for diabetes mellitus.

CMAJ. 2009 Feb 17;180(4):400-7. doi: 10.1503/cmaj.081180.

Cost-effectiveness of insulin analogs.

Am J Manag Care. 2008 Nov;14(11):766-75.

[My quality of life has increased with Lantus].

Lakartidningen. 2004 Sep 23;101(39):3015; discussion 3016.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Hypoglycaemia, analogue insulins; prescribing cost or quality of life?

Diabet Med. 2012 Mar;29(3):289. doi: 10.1111/j.1464-5491.2012.03583.x.

[Are the short-acting insulin analogs superfluous?].

MMW Fortschr Med. 2006 Mar 16;148(11):17.

Insulin lispro: a pharmacoeconomic review of its use in diabetes mellitus.

Pharmacoeconomics. 2002;20(14):989-1025. doi: 10.2165/00019053-200220140-00004.

Long-acting insulin analogs versus human insulins.

Diabetes Technol Ther. 2008 Oct;10(5):331-2. doi: 10.1089/dia.2008.0071.

Hypoglycaemia: costs, insulins and prevention.

Diabet Med. 2016 Apr;33(4):419-20. doi: 10.1111/dme.13100.

Evaluation of exenatide vs. insulin glargine in type 2 diabetes: cost-effectiveness analysis in the German setting.

Diabetes Obes Metab. 2009 Nov;11(11):1068-79. doi: 10.1111/j.1463-1326.2009.01099.x. Epub 2009 Sep 3.

[Economics under scrutiny - experts discuss long acting insulin analogs].

Pflege Z. 2011 Jan;64(1):58.

Cost-effectiveness of insulin analogues for diabetes mellitus.

CMAJ. 2009 Feb 17;180(4):400-7. doi: 10.1503/cmaj.081180.

Cost-effectiveness of insulin analogs.

Am J Manag Care. 2008 Nov;14(11):766-75.

[My quality of life has increased with Lantus].

Lakartidningen. 2004 Sep 23;101(39):3015; discussion 3016.